Elena A. Gilyazitdinova
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 06, 2023
Thrombosis in patients with myeloproliferative neoplasms. Case report
Journal: Terapevticheskii arkhiv
Published: July 20, 2021
The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description
Journal: Terapevticheskii arkhiv
Published: August 26, 2020
Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome
Journal: Terapevticheskii arkhiv
Published: April 16, 2020
Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.
Journal: Terapevticheskii arkhiv
Published: February 01, 2019
Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease
Journal: Terapevticheskii arkhiv
Published: August 03, 2017
Clinical and morphological features of different types of Castleman's disease
Journal: Terapevticheskii arkhiv
Published: September 23, 2015
A case of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with diffuse large B-cell lymphoma and chronic hepatitis B virus infection
Journal: Terapevticheskii arkhiv
Published: December 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026